2023-503617-30-02
EU Clinical Trials Information System
- Trial ID
- T-ctis-2023-503617-30-02
- Registry
- EU Clinical Trials Information System
- CTIS number
- 2023-503617-30-02
- Sponsor, as registered
- Rigshospitalet
- Phase
- Human Pharmacology (Phase I)- Other
- Indication
- Coma and other disorders of consciousness due to acute traumatic and non-traumatic brain injury
- Status
- Authorised
- Start date
- 26/02/2025
- Primary completion
- CTIS does not publish one.
- Member states concerned
- Denmark
- Sites
- 3
Member states whose regulator has a decision on this trial.
euclinicaltrials.euctis registryverified 2026-10-19
Notes on the record
New to data/trials.csv (no row for this CT number on main as of 2026-10-19); found by CTIS public search productName=psilocybin. Product confirmed psilocybin (PEX010) in authorizedPartI; IMP also includes apomorphine. Fields read from the CTIS public API retrieve record on 2026-10-19 17:33 CEST (publishDate 2026-08-14T03:39); site_count is the sum of trialSites across authorizedPartsII; codes not decoded; no primary completion date published.
Cited in
No published issue cites this registry number.